Drug Trial Radar · NCT04747002
Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients.
Last checked: Nov 19, 2026Latest source record: Mar 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Jun 12, 2020
Primary completion
Mar 2024
Study completion Apr 2024
Sponsor
- Lead sponsor
- Osaka UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Japan Agency for Medical Research and Development
- First posted
- Feb 10, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is an investigator-initiated clinical trial (Phase II) using DSP-7888 for acute myeloid leukemia patients with 1st hematological complete remission (CR). DSP-7888 is a novel cocktail peptide vaccine designed to induce cytotoxic T lymphocytes that recognize Wilms Tumor Gene 1 (WT1) peptides.
Conditions
- Acute Myeloid Leukemia in Remission
Interventions
DSP-7888Drug
Cocktail peptide vaccine designed to induce cytotoxic T lymphocytes that recognize WT1 peptides
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relapse-free survivalTime frame: 2 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Osaka University
Suita, Osaka, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.